IBRANCE vs SIROLIMUS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. IBRANCE and SIROLIMUS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	IBRANCE	SIROLIMUS
Rating	64/100	66/100
Pharmacy pays	—	~$48.61 /30
Type	RX	RX
Active ingredient	PALBOCICLIB	SIROLIMUS
Manufacturer	Pfizer	Apotex
Dosage forms	Capsule, Tablet	Solution
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Breast Neoplasms	Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

ibrance sirolimus

Rating

64/100

66/100

Pharmacy pays

—

~$48.61 /30

Type

Active ingredient

PALBOCICLIB

SIROLIMUS

Manufacturer

Pfizer

Apotex

Dosage forms

Capsule, Tablet

Solution

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Breast Neoplasms

Lymphangioleiomyomatosis, Perivascular Epithelioid Cell Neoplasms

Frequently asked questions

Which is better-rated, Ibrance or Sirolimus?

By our independent rating, Sirolimus scores higher — 3.3 vs 3.2 out of 5 for Ibrance. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Ibrance and Sirolimus?

Ibrance contains Palbociclib, while Sirolimus contains Sirolimus — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.